Literature DB >> 3955305

The effects of thyroxine treatment of rats on neuronal and extraneuronal uptake and metabolism of catecholamines in the heart.

L J Bryan, S R O'Donnell, A M Williams.   

Abstract

The effects of thyroxine (T4) treatment of rats on the neuronal and extraneuronal uptake and subsequent metabolism of catecholamines in the heart were examined, to determine whether changes in the local dissipation of catecholamines might contribute to the enhanced sympathetic cardiac responses that occur when thyroid hormone levels are elevated. T4-treated rats were injected subcutaneously with L-thyroxine sodium 1 mg kg(-1) on days 1, 3 and 5, and controls were injected with the normal saline vehicle on the same days. The experiments on isolated, perfused hearts were carried out on day 8. The T4-treated rats had only 50% of the growth rate of the controls and their heart weights were 18% greater than the controls. The experimental data were adjusted to allow for the increase in heart weight caused by the T4 treatment. The initial rates of neuronal uptake of noradrenaline and of extraneuronal uptake of noradrenaline and isoprenaline in the hearts from T4-treated rats were not significantly different from those in hearts from control rats. The steady-state rates of extraneuronal O-methylation of isoprenaline and of extraneuronal deamination of noradrenaline in hearts from T4-treated rats were not significantly different from those in hearts from control rats. The steady-state rate of neuronal deamination of noradrenaline was significantly lower and the accumulation of unmetabolized noradrenaline in the hearts was significantly greater in T4-treated rats than in the controls. These findings could be explained by a decrease in neuronal monoamine oxidase activity or by an increase in intraneuronal binding of noradrenaline in hearts from T4-treated rats. 6 The study has shown that it is unlikely that increased plasma thyroid hormone levels cause cardiac supersensitivity to catecholamines by affecting the local dissipation processes for those amines in the heart.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955305      PMCID: PMC1916536          DOI: 10.1111/j.1476-5381.1986.tb10822.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Thyroid function and the cardiac disposition of catecholamines.

Authors:  R J WURTMAN; I J KOPIN; J AXELROD
Journal:  Endocrinology       Date:  1963-07       Impact factor: 4.736

2.  The effect of triiodothyronine on cyclic AMP, phosphorylase, and adenyl cyclase in rat heart.

Authors:  J H McNeill; L D Muschek; T M Brody
Journal:  Can J Physiol Pharmacol       Date:  1969-11       Impact factor: 2.273

Review 3.  Biochemical and cellular changes in cardiac hypertrophy.

Authors:  M Rabinowitz; R Zak
Journal:  Annu Rev Med       Date:  1972       Impact factor: 13.739

4.  The effect of triiodothyronine pretreatment on amine-induced rat cardiac phosphorylase activation.

Authors:  J H McNeill; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

5.  Thyroid hormone modulation of agonist--beta-adrenergic receptor interactions in the rat heart.

Authors:  G L Stiles; R J Lefkowitz
Journal:  Life Sci       Date:  1981-06-01       Impact factor: 5.037

6.  Quantitative changes in beta-adrenergic responses of isolated atria from hyper- and hypothyroid rats.

Authors:  H P Rub; H Thommen; H Porzig
Journal:  Experientia       Date:  1981-04-15

7.  The isotope effect of tritium in 3H-noradrenaline.

Authors:  U Trendelenburg; F J Stefano; M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

8.  The effects of thyroid hormones on monoamine oxidase in the rat heart.

Authors:  G A Lyles; B A Callingham
Journal:  J Pharm Pharmacol       Date:  1974-12       Impact factor: 3.765

9.  Thyroid hormone regulation of beta-adrenergic receptor number.

Authors:  L T Williams; R J Lefkowitz; A M Watanabe; D R Hathaway; H R Besch
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

10.  Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats.

Authors:  C F Sanford; E E Griffin; K Wildenthal
Journal:  Circ Res       Date:  1978-11       Impact factor: 17.367

View more
  3 in total

1.  Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.

Authors:  L J Bryan-Lluka; H Seers; I Sharpe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

2.  Influence of thyroid status on responses of rat isolated pulmonary artery, vas deferens and trachea to smooth muscle relaxant drugs.

Authors:  S R O'Donnell; J C Wanstall; M B Mustafa
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

3.  A role for corticosterone in the in vivo regulation of the extraneuronal uptake of [3H]-isoprenaline into rat atria.

Authors:  A J Morton
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.